相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling
Chenxu Ge et al.
REDOX BIOLOGY (2022)
Alpinetin inhibits macrophage infiltration and atherosclerosis by improving the thiol redox state: Requirement of GSk3β/Fyn-dependent Nrf2 activation
Doudou Dong et al.
FASEB JOURNAL (2022)
Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity
Ling He et al.
CARDIOVASCULAR TOXICOLOGY (2021)
Doxorubicin-induced and trastuzumab-induced cardiotoxicity in mice is not prevented by metoprolol
Martin Nicol et al.
ESC HEART FAILURE (2021)
Role of acetylation in doxorubicin-induced cardiotoxicity
Daisong Li et al.
REDOX BIOLOGY (2021)
Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway
Yuzhou Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
Xin Zhang et al.
CELL DEATH AND DIFFERENTIATION (2020)
Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy
Rimpy Dhingra et al.
CARDIOVASCULAR RESEARCH (2020)
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Jolanda Sabatino et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2
Yintao Zhao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Mulberrin attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease by promoting Wnt/β-catenin signaling pathway
Wenhui Cao et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2019)
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
Nadine Wenningmann et al.
MOLECULAR PHARMACOLOGY (2019)
Oxidative stress injury in doxorubicin-induced cardiotoxicity
Mei Songbo et al.
TOXICOLOGY LETTERS (2019)
SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function
Panxia Wang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice
Zhen-Guo Ma et al.
CARDIOVASCULAR RESEARCH (2019)
CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1
Yu -Pei Yuan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress
Yue Wang et al.
REDOX BIOLOGY (2018)
Mulberrin (Mul) reduces spinal cord injury (SCI)-induced apoptosis, inflammation and oxidative stress in rats via miroRNA-337 by targeting Nrf-2
Peng Xia et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice
Jing Ye et al.
EBIOMEDICINE (2018)
Autophagic dysregulation in doxorubicin cardiomyopathy
Jordan J. Bartlett et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
A Circular RNA Binds To and Activates AKT Phosphorylation and Nuclear Localization Reducing Apoptosis and Enhancing Cardiac Repair
Yan Zeng et al.
THERANOSTICS (2017)
Sulforaphane protects the heart from doxorubicin-induced toxicity
Preeti Singh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
How do nutritional antioxidants really work: Nucleophilic tone and para-hormesis versus free radical scavenging in vivo
Henry J. Forman et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction
Siying Li et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Adiponectin Ameliorates Doxorubicin-induced Cardiotoxicity through Akt Protein-dependent Mechanism
Sonomi Maruyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity
Guo-Chang Fan et al.
CIRCULATION RESEARCH (2008)
Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice
Alexander Riad et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Mitochondrial and nuclear p53 localization in cardiomyocytes: Redox modulation by doxorubicin (adriamycin)?
Ramaneeya Nithipongvanitch et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Gp91phox-containing NAD(P)H oxidase increases superoxide fonnation by doxorubicin and NADPH
Shiwei Deng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidase
Ye Xiong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
Y Shizukuda et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia
SE Lipshultz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
